论文部分内容阅读
目的分析托吡酯片(妥泰)联合丙戊酸钠治疗难治性癫痫的应用价值。方法 150例难治性癫痫患者随机分为对照组和观察组,每组75例;对照组给予原用癫痫药物和丙戊酸钠治疗,观察组在对照组的基础上同时给予妥泰联合治疗,1个疗程后观察两组的临床疗效和不良反应,并进行对比。结果观察组总有效率89.33%优于对照组的64.00%,差异有统计学意义(P<0.05);两组患者的不良反应发生情况比较,差异无统计学意义(P>0.05)。结论妥泰联合丙戊酸钠在治疗难治性癫痫中具有显著的疗效,可有效地改善患者的临床症状,提高患者的生活质量,在临床上具有很好的应用价值。
Objective To analyze the clinical value of topiramate combined with sodium valproate in the treatment of refractory epilepsy. Methods 150 patients with refractory epilepsy were randomly divided into control group and observation group, with 75 cases in each group. The control group was given epilepsy drugs and sodium valproate. The observation group was treated with topiramate combined with the control group After a course of treatment, the clinical efficacy and adverse reactions of the two groups were observed and compared. Results The total effective rate in the observation group was 89.33%, which was significantly higher than 64.00% in the control group (P <0.05). There was no significant difference in adverse reactions between the two groups (P> 0.05). Conclusion Topiramate combined with sodium valproate in the treatment of refractory epilepsy has a significant effect, which can effectively improve the clinical symptoms of patients and improve the quality of life of patients with clinical application has a good value.